Skip to main content

Table 1 CRS grading scales: Penn grading scale, CTCAE v4.0, 2014 Lee et al. scale, and MDACC grading

From: Cytokine release syndrome: grading, modeling, and new therapy

 

Penn grading scale

CTCAE v4.0

2014 Lee et al.

MDACC

Grade 1

Mild reaction: treated with supportive care such as antipyretics and antiemetics

Mild reaction; infusion interruption not indicated; intervention not indicated

Symptoms are not life-threatening and require symptomatic treatment only, e.g., fever, nausea, fatigue, headache, myalgias, and malaise

Temperature ≥ 38 °C (fever) or grade 1 organ toxicity

Grade 2

Moderate reaction: some signs of organ dysfunction (e.g., grade 2 creatinine or grade 3 LFTs) related to CRS and not attributable to any other condition. Hospitalization for management of CRS-related symptoms, including fevers with associated neutropenia and need for IV therapies (not including fluid resuscitation for hypotension)

Therapy or infusion interruption indicated but responds promptly to symptomatic treatment (e.g., antihistamines, NSAIDs, narcotics, IV fluids); prophylactic medications indicated for ≤ 24 h

Symptoms require and respond to moderate intervention. Oxygen requirement < 40% or hypotension responsive to fluids or low-dose pressors or grade 2 organ toxicity

Systolic blood pressure < 90 mmHg (hypotension) but responds to IV fluids or low-dose vasopressors or needing oxygen(FiO2 < 40%) for SaO2 > 90% (hypoxia) or grade 2 organ toxicity

Grade 3

More severe reaction: hospitalization required for management of symptoms related to organ dysfunction, including grade 4 LFTs or grade 3 creatinine related to CRS and not attributable to any other conditions; this excludes management of fever or myalgias; includes hypotension treated with IV fluids (defined as multiple fluid boluses for blood pressure support) or low-dose vasopressors, coagulopathy requiring fresh frozen plasma or cryoprecipitate or fibrinogen concentrate, and hypoxia requiring supplemental oxygen (nasal cannula oxygen, high-flow oxygen, CPAP, or BiPAP). Patients admitted for management of suspected infection due to fevers and/or neutropenia may have grade 2 CRS

Prolonged reaction (e.g., not rapidly responsive to symptomatic medication and/or brief interruption of infusion); recurrence of symptoms following initial improvement; indicated for clinical sequelae (e.g., renal impairment, pulmonary infiltrates)

Symptoms require and respond to aggressive intervention. Oxygen requirement ≥ 40% or hypotension requiring high-dose or multiple pressors or grade 3 organ toxicity or grade 4 transaminitis

Systolic blood pressure < 90 mmHg (hypotension) and needs high-dose or multiple vasopressors or needing oxygen(FiO2 ≥ 40%) for SaO2 > 90% (hypoxia) or grade 3 organ toxicity or grade 4 transaminitis

Grade 4

Life-threatening complications such as hypotension requiring high-dose vasopressors and a hypoxia requiring mechanical ventilation

Life-threatening consequences; pressor or ventilator support indicated

Life-threatening symptoms. Requirements for ventilator support or grade 4 oxygen toxicity (excluding transaminitis)

Life-threatening hypotension or needing ventilator support or grade 4 oxygen toxicity (excluding transaminitis)

  1. BiPAP bilevel positive airway pressure, CPAP continuous positive airway pressure therapy, CRS cytokine release syndrome, CTCAE Common Terminology Criteria for Adverse Events, IV intravenous, LFT liver function test, NSAID nonsteroidal anti-inflammatory drug, FiO2 fraction of inspired oxygen, SaO2 arterial oxygen saturation
  2. aSee specific definition of high-dose vasopressors [41]